C1QTNF3 and diabetes mellitus: A recent study by Yan et al. [28] reported the therapeutic potential of CTRP3 on the diabetic retina by reducing the vascular permeability, preserving the function of the inner blood-retinal barrier in NPDR via inhibiting diabetes-suppressed the expression of Occludin and Claudin-5 in an AMPK-dependent manner.